Uncategorized
Baltimore / Biotechnology / Competitions / InvestMaryland

Plasmonix to launch QuantArray, which detects microscopic cells for research

Plasmonix, the bioanalysis technology company that was one of the first companies to receive a (small) piece of the $84 million InvestMaryland fund, plans to launch its first product early this year, reports BmoreMedia. The product, QuantArray, “has various applications in performing assays, a test that analyzes components, and enhances luminescent signals hundred-fold over conventional methods,” according to BmoreMedia. At […]

Plasmonix, the bioanalysis technology company that was one of the first companies to receive a (small) piece of the $84 million InvestMaryland fund, plans to launch its first product early this year, reports BmoreMedia.
The product, QuantArray, “has various applications in performing assays, a test that analyzes components, and enhances luminescent signals hundred-fold over conventional methods,” according to BmoreMedia.
At the heart of Plasmonix’s business is metal-enhanced fluorescence, which is a process used to detect cells in medical and clinical research. The technology behind Plasmonix’s business has applications not only in the medical field, but also in cosmetics, paints and lighting.
Founded in 2009, Plasmonix occupies space in UMBC‘s Research and Technology Park, and has four employees now.

Companies: University of Maryland, Baltimore County (UMBC) / Plasmonix
Subscribe

Knowledge is power!

Subscribe for free today and stay up to date with news and tips you need to grow your career and connect with our vibrant tech community.

Trending

WeWork approached physical space as if it were virtual — which led to the company’s downfall

The Tech Behind: How Baltimore's Washington Monument gets lit every winter holiday

Download the inaugural State of the Baltimore Tech Economy Report

Baltimore, let’s celebrate: You picked these 5 winners for your 2023 Technical.ly Awards

Technically Media